News
Article
Pharmaceutical Technology
Author(s):
In this article, the authors look at the limitations of the validation for a single-use shipping system and provide a perspective on what shipping validation means.
As the biotech industry evolves, there are mounting concerns about the transportation, security, and robustness of cell-culture media, intermediate, or bulk drug substance (BDS). Safe, stable, and closed systems are needed when sterile products are shipped in single-use bags. In this article, the authors look at the limitations of the validation for a single-use shipping system and provide a perspective on what shipping validation means.
Download
Pharmaceutical Technology’s 2016 Bioprocessing and Sterile Manufacturing eBook.
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.